Baumann-Vogel Heide, Imbach Lukas L, Sürücü Oguzkan, Stieglitz Lennart, Waldvogel Daniel, Baumann Christian R, Werth Esther
Department of Neurology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.
Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zürich, Switzerland.
Sleep. 2017 May 1;40(5). doi: 10.1093/sleep/zsx033.
This prospective observational study was designed to systematically examine the effect of subthalamic deep brain stimulation (DBS) on subjective and objective sleep-wake parameters in Parkinson patients.
In 50 consecutive Parkinson patients undergoing subthalamic DBS, we assessed motor symptoms, medication, the position of DBS electrodes within the subthalamic nucleus (STN), subjective sleep-wake parameters, 2-week actigraphy, video-polysomnography studies, and sleep electroencepahalogram frequency and dynamics analyses before and 6 months after surgery.
Subthalamic DBS improved not only motor symptoms and reduced daily intake of dopaminergic agents but also enhanced subjective sleep quality and reduced sleepiness (Epworth Sleepiness Scale: -2.1 ± 3.8, p < .001). Actigraphy recordings revealed longer bedtimes (+1:06 ± 0:51 hours, p < .001) without shifting of circadian timing. Upon polysomnography, we observed an increase in sleep efficiency (+5.2 ± 17.6%, p = .005) and deep sleep (+11.2 ± 32.2 min, p = .017) and increased accumulation of slow-wave activity over the night (+41.0 ± 80.0%, p = .005). Rapid eye movement sleep features were refractory to subthalamic DBS, and the dynamics of sleep as assessed by state space analyses did not normalize. Increased sleep efficiency was associated with active electrode contact localization more distant from the ventral margin of the left subthalamic nucleus.
Subthalamic DBS deepens and consolidates nocturnal sleep and improves daytime wakefulness in Parkinson patients, but several outcomes suggest that it does not normalize sleep. It remains elusive whether modulated activity in the STN directly contributes to changes in sleep-wake behavior, but dorsal positioning of electrodes within the STN is linked to improved sleep-wake outcomes.
本前瞻性观察性研究旨在系统地研究丘脑底核深部脑刺激(DBS)对帕金森病患者主观和客观睡眠-觉醒参数的影响。
在50例连续接受丘脑底核DBS治疗的帕金森病患者中,我们评估了运动症状、药物治疗、DBS电极在丘脑底核(STN)内的位置、主观睡眠-觉醒参数、为期2周的活动记录仪监测、视频多导睡眠图研究,以及手术前和术后6个月的睡眠脑电图频率和动态分析。
丘脑底核DBS不仅改善了运动症状,减少了多巴胺能药物的每日摄入量,还提高了主观睡眠质量并减轻了嗜睡程度(爱泼华嗜睡量表:-2.1±3.8,p<.001)。活动记录仪记录显示睡眠时间延长(+1:06±0:51小时,p<.001),且昼夜节律时间未发生改变。在多导睡眠图检查中,我们观察到睡眠效率提高(+5.2±17.6%,p=.005)、深度睡眠增加(+11.2±32.2分钟,p=.017)以及夜间慢波活动积累增加(+41.0±80.0%,p=.005)。快速眼动睡眠特征对丘脑底核DBS不敏感,通过状态空间分析评估的睡眠动态未恢复正常。睡眠效率提高与距左侧丘脑底核腹侧边缘较远的有效电极触点定位有关。
丘脑底核DBS可加深并巩固帕金森病患者的夜间睡眠,改善白天的清醒状态,但多项结果表明其并未使睡眠恢复正常。STN中调制活动是否直接导致睡眠-觉醒行为的改变仍不清楚,但电极在STN内的背侧定位与改善睡眠-觉醒结果有关。